Abstract
Chlorine (Cl2) is an important industrial chemical. Accidental full body exposure to Cl2 poses an environmental, occupational, and public health hazard characterized mainly by injury to the lung, skin, and ocular epithelia. The cellular mechanisms underlying its acute toxicity are incompletely understood. This study examined whether whole body exposure of BALB/c mice to Cl2 in environmental chambers leads to the up-regulation of the unfolded protein response (UPR) in their lungs and skin. Shaved BALB/c mice were exposed to a sublethal concentration of Cl2 (400 ppm for 30 min) and returned to room air for 1 or 6 hours and killed. IL-6 and TNF-α were increased significantly at 1 and 6 hours after Cl2 exposure in the lungs and at 6 hours in the skin. These changes were accompanied by increased UPR signaling (i.e., activation of protein kinase RNA-like endoplasmic reticulum kinase, inositol-requiring enzyme 1 α, and activating transcription factor 6α) at these time points. The expression of hepcidin, which regulates tissue accumulation and mobilization of iron, was increased in the skin and lungs of Cl2–exposed mice. The data shown herein indicate for the first time the up-regulation of UPR signaling and hepcidin in the skin and lungs of Cl2–exposed mice, which persisted when the mice were returned to room air for 6 hours.
Key words: hepcidin, inflammation, unfolded protein response, TNF-α, IL-6
Clinical Relevance
Exposure to chlorine constitutes a major public threat. We show that exposure to chlorine up-regulates the unfolded protein response signaling and hepcidin in the skin and lungs of Cl2–exposed mice, which persisted when the mice were returned to room air for 6 hours. Our findings form the rational basis for development of selective agents to ameliorate Cl2–induced morbidity and mortality
Chlorine gas (Cl2) is an important industrial chemical (1). In the United States, Europe, and other parts of the world, several million tons of Cl2 are produced annually. Its accidental release in the atmosphere may cause significant mortality and morbidity to humans and animals. Its exposure primarily leads to pulmonary edema and to restrictive and obstructive lung diseases. Other clinical symptoms include dyspnea, cough, pneumonitis, cyanosis, nausea, vomiting, and loss of consciousness (2–6).
Cl2 is a strong oxidant. Its exposure rapidly augments reactive oxygen species (ROS) generation and depletes tissue antioxidants such as glutathione and ascorbic acid (7–9). It manifests its toxicity via oxidative damage to lung epithelial cells, leading to egress of plasma proteins from the vascular to the alveolar spaces, production of inflammatory mediators, influxes of neutrophils into lung tissue, and reactive airway disease syndrome (10–13). Systemic injury, characterized by inflammation and inactivation of nitric oxide synthase, has also been reported (14). Postexposure administration of ascorbate and deferoxamine in mice exposed to 600 ppm Cl2 for 45 minutes decreased mortality, injury to the blood–gas barrier, and lipid peroxidation (2, 9). Similarly, postexposure administration of AEOL10150, a peroxynitrite scavenger, in Cl2–treated mice decreased airway hyperresponsiveness, inflammation, and 4-hydroxynonenal level, a marker of lipid peroxidation (15).
Many groups have investigated the molecular mechanisms of Cl2 toxicity in humans and in experimental animals, with the goal of developing novel and molecular targeted antidotes against Cl2 toxicity. In this regard, cyclic AMP regulating enzyme, type 4 phosphodiesterase (16), NF-kβ, neurokinin 1 receptor (17), nuclear factor (erythroid-derived 2)-like 2 (18, 19), and extracellular signal-regulated kinases–dependent disruption of amiloride-sensitive Na+ channels in alveolar Type I and II cells (7) were shown to be involved in the molecular pathogenesis of acute Cl2 toxicity; inhibitors of these molecular targets afforded some protection against Cl2–induced pulmonary damage. The resulting inflammatory response plays an important role in the potentiation of Cl2–induced injury once animals are returned to room air (9, 11, 12, 17).
One important pathway associated with the onset of inflammation is the unfolded protein response (UPR) signaling pathway. UPR signaling contributes to the repair of misfolded proteins and protects against the degradation of unfolded proteins by inducing expression of a number of chaperone proteins after endoplasmic reticulum (ER) stress (20). However, prolonged activation of this pathway underlies pathogenesis of the inflammatory response (21). Because the tissue-damaging effects of Cl2 are known to be initiated by reactive species (1), we decided to test if Cl2 exposure affects UPR responses.
UPR signaling is activated through three ER resident proteins (inositol-requiring enzyme 1 α [IRE1α], protein kinase RNA-like endoplasmic reticulum kinase [PERK], and activating transcription factor 6α [ATF6α]) in a phosphorylation- or proteolysis-dependent manner (see Figure E1 in the online supplement). The activation of these three branches of UPR collectively regulates downstream events, including splicing of Xbp1 mRNA and expression of UPR target genes such as C/EBP homology protein (CHOP), glucose-regulated protein (GRP)94, and GRP78, a UPR regulator and ER chaperone (22). Reactive species are thought to be one of multiple triggers associated with UPR signaling pathways. In this regard, Winter and colleagues showed that bleach, which mainly contains hypochlorous acid, activates a redox-regulated chaperone by oxidative protein unfolding in bacteria (23). This in vitro study established the rational basis for further testing possible up-regulation of UPR in the skin and lungs of mice exposed to Cl2 gas.
We show that whole body exposure of mice to sublethal concentration of Cl2 (400 ppm for 30 min) induces inflammatory response in the lungs and skin once the mice resume air breathing. In both of these organs, similar but not identical alterations in inflammatory responses were noted, which were associated with the activation of UPR. We report for the first time that UPR signaling–regulated tissue iron metabolism may be disrupted by Cl2 exposure. These findings help to explain why postexposure administration of deferoxamine, a free iron chelator, in mice exposed to lethal concentrations of Cl2 decreased mortality and lung injury (2).
Materials and Methods
Reagents
The primary antibodies used in this study were Ki67 (sc-15402; Santa Cruz, Dallas, TX), p-PERK (sc-32577; Santa Cruz), PERK (3192 s; Cell Signaling, Danvers, MA), phosphorylated eukaryotic initiation factor-α (p-eIF2α) (9721; Cell Signaling), eIF2α (9722; Cell Signaling), CHOP (2895, Cell Signaling), ATF6α (sc-22799; Santa Cruz), GRP78 (sc-1050; Santa Cruz), GRP94 (2104, Cell Signaling), β-actin (A-5316; Sigma, St. Louis, MO). Primers as described in Table E1 in the online supplement were synthesized by Invitrogen (Grand Island, NY). An In Situ Cell Death Detection kit (Catalog no. 11684795910) was purchased from Roche Diagnostics (Indianapolis, IN).
Animals
BALB/c female mice (20–25 g) were purchased from Charles River Laboratories (Wilmington, MA). All experimental procedures involving animals were approved by the University of Alabama at Birmingham Institutional Animal Care and Use Committee.
Exposure of Mice to Cl2
Mice were placed in an environmental chamber and exposed to Cl2 in air (400 ppm for 30 min) as previously described (2). Before exposure, the fur was removed (24) (see Methods in the online supplement for more details) so the unprotected skin would be exposed to Cl2. Immediately after the exposure, mice were returned to room air, where they breathed ambient air for 1 or 6 hours. Food and water were provided ad libitum.
Western Blot
Western blots were performed as previously described (25). The integrated density of bands was measured with ImageJ software (http://rsb.info.nih.gov/ij/). Statistical analysis was conducted using Excel 2003.
Immunofluorescence
Immunofluorescence staining was performed as described previously (25).
Immunohistochemistry
Immunohistochemistry staining was performed using EXPOSE Mouse and Rabbit Specific HRP/DAB Detection IHC Kit (ab94710; Abcam, Cambridge, MA) according to the manufacturer’s standard protocol.
Measurements of ROS
ROS levels in lung tissues were measured using the chloromethyl derivative of 2′,7′-dichlorodihydrofluorescein diacetate (CM-H2DCFDA, c6827; Invitrogen Life Technologies, Grand Island, NY) as described previously (25).
Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling Assay
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) measurements were performed according to the manufacturer’s standard protocol (27).
RT-PCR and Real-Time PCR
RT-PCR was performed as described previously (25). The integrated band densities were measured by Image J software. The cycle number for each gene was chosen within an exponential amplification stage instead of an end point. In each sample, band densities for each gene were normalized by a housekeeping gene. Real-time PCR was performed in iQ SYBR Green PCR Master Mix (170-8880; Bio-Rad, Hercules, CA). A comparative ΔΔCt method was used in the quantification.
Statistical Analysis
Statistical analysis was performed using the Student’s t test. A P value < 0.05 was considered to be statistically significant.
Results
Effects of Cl2 Exposure on the Expression of Cytokines in the Skin and Lungs
Exposure of mice to 400 ppm Cl2 for 30 minutes results in arterial hypoxemia; respiratory acidosis; increased levels of albumin, IgG, and IgM in bronchoalveolar lavage fluid; increased bronchoalveolar lavage fluid surfactant surface tension; and significant histological injury to airway and alveolar epithelia (8). Whole body exposure of BALB/c shaved mice to Cl2 increased proinflammatory cytokine mRNA levels in the skin and lungs (Figure 1). In the skin, transcriptional expression of IL-1β was significantly increased at 1 hour but returned to its baseline value at 6 hours after exposure. The expression of IL-6 mRNA was up-regulated significantly in a time-dependent manner. However, TNF-α was significantly increased only at 6 hours (Figure 1A). In the lung, IL-1β, TNF-α, and IL-6 were highly induced at 1 and 6 hours (Figure 1B). As compared with their respective controls, IL-6 increased 5- and 70-fold in the skin and lungs, respectively, at 6 hours after exposure. The changes in TNF-α and IL-6 are similar to those reported by Song and colleagues in unshaved Balb/c mice exposed to 400 ppm Cl2 for 30 minutes and returned to room air (12).
Figure 1.
Cl2 induces cytokines expression in the skin and lung of BALB/c mice. Real-time PCR shows enhancement in the cutaneous transcript levels of IL-1β, TNF-α, and IL-6 (A) and enhancement in the pulmonary transcript levels of IL-1β, TNF-α, and IL-6 (B). *P < 0.05 and **P < 0.01 when compared with control. Mean ± SEM (n = 3).
Effects of Cl2 Exposure on UPR Signaling in the Skin and Lung
In the skin, significant increases in the expression of GRP78 and ATF6α p50 protein levels were seen at 1 and 6 hours after exposure. p-PERK/PERK and ATF6α p90 were elevated at 1 hour but returned to control levels at 6 hours, and CHOP protein levels were increased at 6 hours only (Figure 2A and Figure E2A). Similarly, the mRNA levels of GRP78, spliced form of X-box binding protein 1 (Xbp1s) and CHOP, were increased at 6 hours after exposure (Figure 2B). The expression of p-eIF2α protein, which is known to shut down the overall translation machinery (20), was not altered in the skin (Figure E2A). ATF6α, a transcription factor that regulates multiple UPR target proteins (20), showed enhanced nuclear expression mostly at 6 hours after exposure (Figure E2B) in epidermis keratinocytes by immunofluorescence. Similarly, CHOP, another UPR-related transcription protein, which regulates apoptosis, was significantly enhanced in Cl2–exposed epidermis at 1 hour and to a larger extent at 6 hours after exposure (Figure 2C).
Figure 2.
Cl2 alters unfolded protein response (UPR) signaling–related proteins in the skin. (A) Western blot analysis of tissue total protein extract. Bars are means ± SEM. (B) Real-time PCR shows cutaneous transcript levels of the spliced form of X-box binding protein 1 (Xbp1s), C/EBP homology protein (CHOP), and glucose-regulated protein (GRP)78. In A and B, *P < 0.05 and **P < 0.01 when compared with control. Bars represent mean ± SEM (n = 3). (C) Immunofluorescence staining showing tissue localization and expression of CHOP. White arrows indicate the nuclear localization of CHOP. Original magnification: ×20. (D) Pictures show Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining in control and Cl2–exposed skin. Red arrows indicate the TUNEL-positive cells in the epidermis. Original magnification: ×40. (E) Pictures show Ki67 staining in control and Cl2–exposed skin. Green arrows indicate Ki67 nuclear staining in basal and super-basal layers of epidermis. In C, D, and E, the region above the dotted line represents epidermis, and the region below this line is dermis. Each staining is representative of three independent skin samples. (F) Histology of the skin. Pictures show H&E staining of skin. Original magnification: ×40. Each picture is representative of three independent skin samples. DER = dermis; EPI = epidermis.
Sustained activation of CHOP is also known to induce apoptotic cell death (26). Therefore, we assessed whether Cl2 exposure induces apoptosis in the skin. Whereas TUNEL-positive cells were rare in the skin of control mice, multiple TUNEL-positive cells were seen in the epidermis, particularly in and around the hair follicles, of Cl2–exposed mice (Figure 2D). In the skin of control mice, Ki67 staining was seen only in a few basal epidermal cells; however, in Cl2–exposed mice, Ki67 staining was present in the basal layer of their skin (Figure 2E). These results indicate that Cl2 exposure increased cell proliferation due to cell death or the onset of inflammation; the latter may lead to UPR up-regulation. Consistent with these findings, increased thickness of the epidermis was observed at 6 hours after exposure (Figure 2F).
In the lung, Cl2 exposure resulted in significant increases of p-PERK/PERK and p-eIF2α protein levels at 1 hour, which returned to control levels at 6 hours after exposure (Figure 3A and Figure E3A). Real-time PCR data showed an increase in the lung GRP78 mRNA at 1 hour (Figure 3B). Significant increases in the nuclear localization of CHOP and ATF6α were observed in bronchial epithelial cells (which encountered higher concentrations of Cl2 as compared with alveolar epithelial cells) at 6 hours after Cl2 exposure (Figure 3C). GRP78, a cytoplasmic protein, was also elevated in bronchial epithelial cells (Figure E3B). These findings are consistent with up-regulation of two branches of the UPR signaling (Figure E1) in the lungs, and more specifically in bronchial epithelial cells, after Cl2 exposure.
Figure 3.
Cl2 alters unfolded protein response (UPR) signaling–related proteins in the lung. (A) Western blot analysis of tissue total protein extract. Bars are means ± SEM (n = 3) for the indicated proteins. (B) Real-time PCR shows pulmonary transcript levels of Xbp1 s, CHOP, and GRP78. In A and B, *P < 0.05 and **P < 0.01. Bars represent mean ± SEM. (C) Immunohistochemical staining shows tissue localization and expression of CHOP and activating transcription factor 6α (ATF6α) in bronchial epithelial cells. Original magnification: ×40. (D) Histology of the lung. Pictures show H&E staining of lung. Original magnification: ×40. Each picture is representative of three independent lung samples. (E) Pictures show TUNEL staining in control and chlorine-exposed lung samples. Red arrows indicate the TUNEL-positive cells in the lung. Original magnification: ×40.
Because UPR signaling is intricately regulated by ROS, we also determined whether Cl2 exposure enhanced lung ROS levels using an oxidant-sensitive probe (CM-H2DCFDA) that enters cells and remains in their cytoplasm . Increased green fluorescence, indicative of higher levels of ROS, was seen in lung tissues from mice exposed to Cl2 and returned to room air for 1 and 6 hours (Figure E3C). These results are in agreement with previous findings showing up-regulation of reactive intermediates in alveolar type II cells exposed to Cl2 and returned to room air for up to 24 hours (7). Consistent with the effects of Cl2 on the enhancement of cytokine expression, lung sections of Cl2–exposed mice showed increased cellularity and congestion (Figure 3D), confirming the earlier reports (9). We also observed an enhanced presence of TUNEL-positive cells in the lung excised from Cl2–exposed animals (Figure 3E), which is consistent with the earlier published observations (27, 28).
Effects of Cl2 on the Disruption of Iron Metabolism
It has been reported that iron metabolism is under the control of the UPR signaling pathway (29) by altering hepcidin expression. Here, we observed that Cl2 exposure enhanced transcript levels of hepcidin antimicrobial peptide (Hamp) in the skin and lungs (Figures 4A and 4C). The expression of solute carrier family 40 (iron-regulated transporter), member 1 (Slc40a1) mRNA levels, which codes for a binding receptor of hepcidin (30), was also significantly enhanced at 6 hours in skin and lung of Cl2–exposed mice (Figures 4A and 4C). Immunofluorescence studies showed increased ferroportin and hepcidin protein levels in lungs and skin of Cl2–exposed mice (Figures 4B and 4D).
Figure 4.
Cl2 enhances transcript and protein levels of iron homeostasis–regulating proteins hepcidin and ferroportin. (A) RT-PCR shows cutaneous transcript levels of hepcidin antimicrobial peptide (Hamp) and Slc40a1. 18 s rRNA was used as loading control. Graphs show statistical analysis of normalized band density of each gene when compared with control. Bars represent means ± SEM (n = 3). (B) Immunofluorescence staining shows the expression of ferroportin and hepcidin in the skin. Original magnification: ×40. The region above the dotted line represents epidermis; the region below this line is dermis. (C) RT-PCR shows pulmonary transcript levels of Hamp and Slc40a1. 18 s rRNA was used as loading control. Graphs show statistical analysis of normalized band density of each gene when compared with control. *P < 0.05 when compared with control. Bars represent means ± SEM (n = 3). (D) Immunofluorescence staining shows tissue expression of ferroportin and hepcidin in the lung. Original magnification: ×20. White arrows indicate the expression of ferroportin and hepcidin in bronchial epithelia. White dotted line separates the area of bronchi from alveoli. Each picture is representative of three independent lung samples. ALV = alveoli; BR = bronchi; DER = dermis; EPI = epidermis.
Discussion
Cl2 is known to increase ROS and to deplete tissue antioxidant levels in alveolar type II and airway epithelial cells of the lung tissues (7, 15, 27); thus, the generated ROS are not rapidly detoxified. This provides an opportunity for ROS to act for an extended time period, which seems to be a trigger for early and sustained tissue injury. This is consistent with our observations that Cl2 exposure induces sustained ROS production in the lung, which could be visualized up to 6 hours after exposure (Figure E3C). Cl2 is a known pulmonary inflammation-inducing chemical. In this study, we found that whole body Cl2 gas exposure enhanced inflammation not only in the lung but also in the skin. These inflammatory responses were associated with the enhanced expression of cytokines in the two organs as also confirmed in this study.
Recent studies have focused on defining the intricate relationship between inflammation and UPR signaling (24). Cytokines (e.g., IL-1β, TNF-α, and IL-6) and ROS generation are known to enhance UPR signaling pathway (21, 31), and both of these agonists of the UPR signaling pathways are induced by Cl2. As observed in this study, Cl2 exposure enhanced the transcript and protein levels of UPR pathway genes (Figure E1), which may be mediated by the enhanced cytokine levels and by ROS generation. However, the observed depletion in the protein level of some of these UPR-regulatory molecules in the lung, particularly at later time points, indicates that Cl2 induces a protein translational block due to augmented expression of p-eIF2α, a protein known to manifest a global translation inhibition during the ER stress, and/or induces proteasomal degradation of unfolded or misfolded proteins due to prolonged ROS generation (20).
Hepcidin, a defensin-like peptide, serves as a master regulator of iron homeostasis and innate immunity (29, 32). The molecular pathways regulating hepcidin expression are orchestrated by the complex responses of UPR-regulated XBP-1, IL-6/signal transducer, and activator of transcription 3 and transcription factor cAMP responsive element binding protein 3-like 3 (29, 33, 34). We observed an enhancement in the mRNA level of hepcidin after Cl2 exposure, which may be due to Cl2–induced enhanced production of IL-6 in lung and skin. Under normal physiological conditions, hepdicin triggers the degradation of iron exporter ferroportin to restore the tissue level of iron (35). In this study, enhanced hepcidin was not able to reduce ferroportin level, suggesting that Cl2 impairs the iron homeostasis regulatory function of hepcidin. Enhanced levels of ferroportin may lead to the release of tissue-bound iron. It is likely that Cl2 exposure creates a pool of loosely bound iron that is known to be redox active and initiates free radical–mediated tissue damage (36). In earlier studies, we showed a role of iron in mediating acute Cl2 toxicity, as administration of the iron chelator; deferoxamine reduced Cl2–induced mortality in mice and rats (2, 8, 9).
In summary, these studies reveal that Cl2 damages skin in addition to lung tissue. The data presented herein indicate for the first time the up-regulation of UPR signaling and hepcidin levels in the skin and lungs of Cl2–exposed mice, which persisted when the mice returned to room air for 6 hours.
Acknowledgments
Acknowledgments
The authors thank Ms. Gloria Y. Son for editing this manuscript and Dr. Asta Jurkuvenaite for useful discussions on this topic.
Footnotes
This work was supported by National Institutes of Health grants R21 AR 064,595 (National Institute of Musculoskeletal and Skin Diseases) (M.A), 5U01ES015676 (National Institute of Environmental Health Sciences) (S.M.), and 5U54ES017218 (National Institute of Environmental Health Sciences) (S.M.). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Authors Contributions: C.L.: Study design, data acquisition and analysis, interpretation of the information, contributed to the writing of the manuscript. Z.W.: Data acquisition and analysis. S.F.D.: Data acquisition and analysis. R.K.S.: Study design, data acquisition and analysis. F.A.: Study design, data acquisition and analysis. S.M.: Study design, interpretation of the information, writing of the article, responsible for quality control. M.A.: Study design, interpretation of the information, writing of the article. responsible for quality control.
This article has an online supplement, which is accessible from this issue's table of contents at www.atsjournals.org
Originally Published in Press as DOI: 10.1165/rcmb.2012-0488RC on May 13, 2013
Author disclosures are available with the text of this article at www.atsjournals.org.
References
- 1.Squadrito GL, Postlethwait EM, Matalon S. Elucidating mechanisms of chlorine toxicity: reaction kinetics, thermodynamics, and physiological implications. Am J Physiol Lung Cell Mol Physiol. 2010;299:L289–L300. doi: 10.1152/ajplung.00077.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Zarogiannis SG, Jurkuvenaite A, Fernandez S, Doran SF, Yadav AK, Squadrito GL, Postlethwait EM, Bowen L, Matalon S. Ascorbate and deferoxamine administration after chlorine exposure decrease mortality and lung injury in mice. Am J Respir Cell Mol Biol. 2011;45:386–392. doi: 10.1165/rcmb.2010-0432OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hoyle GW. Mitigation of chlorine lung injury by increasing cyclic AMP levels. Proc Am Thorac Soc. 2010;7:284–289. doi: 10.1513/pats.201001-002SM. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Jones R, Wills B, Kang C. Chlorine gas: an evolving hazardous material threat and unconventional weapon. West J Emerg Med. 2010;11:151–156. [PMC free article] [PubMed] [Google Scholar]
- 5.Van Sickle D, Wenck MA, Belflower A, Drociuk D, Ferdinands J, Holguin F, Svendsen E, Bretous L, Jankelevich S, Gibson JJ, et al. Acute health effects after exposure to chlorine gas released after a train derailment. Am J Emerg Med. 2009;27:1–7. doi: 10.1016/j.ajem.2007.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Bell DG. Management of acute respiratory distress syndrome (ARDS) following chlorine exposure [abstract] Am J Respir Crit Care Med. 2008;176:A314. [Google Scholar]
- 7.Lazrak A, Chen L, Jurkuvenaite A, Doran SF, Liu G, Li Q, Lancaster JR, Jr, Matalon S. Regulation of alveolar epithelial Na+ channels by ERK1/2 in chlorine-breathing mice. Am J Respir Cell Mol Biol. 2012;46:342–354. doi: 10.1165/rcmb.2011-0309OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Leustik M, Doran S, Bracher A, Williams S, Squadrito GL, Schoeb TR, Postlethwait E, Matalon S. Mitigation of chlorine-induced lung injury by low-molecular-weight antioxidants. Am J Physiol Lung Cell Mol Physiol. 2008;295:L733–L743. doi: 10.1152/ajplung.90240.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fanucchi MV, Bracher A, Doran SF, Squadrito GL, Fernandez S, Postlethwait EM, Bowen L, Matalon S. Post-exposure antioxidant treatment in rats decreases airway hyperplasia and hyperreactivity due to chlorine inhalation. Am J Respir Cell Mol Biol. 2012;46:599–606. doi: 10.1165/rcmb.2011-0196OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hoyle GW, Chang W, Chen J, Schlueter CF, Rando RJ. Deviations from Haber's law for multiple measures of acute lung injury in chlorine-exposed mice. Toxicol Sci. 2010;118:696–703. doi: 10.1093/toxsci/kfq264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Tian X, Tao H, Brisolara J, Chen J, Rando RJ, Hoyle GW. Acute lung injury induced by chlorine inhalation in C57BL/6 and FVB/N Mice. Inhal Toxicol. 2008;20:783–793. doi: 10.1080/08958370802007841. [DOI] [PubMed] [Google Scholar]
- 12.Song W, Wei S, Liu G, Yu Z, Estell K, Yadav AK, Schwiebert LM, Matalon S. Postexposure administration of a {Beta}2-agonist decreases chlorine-induced airway hyperreactivity in mice. Am J Respir Cell Mol Biol. 2011;45:88–94. doi: 10.1165/rcmb.2010-0226OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Song W, Wei S, Zhou Y, Lazrak A, Liu G, Londino JD, Squadrito GL, Matalon S. Inhibition of lung fluid clearance and epithelial Na+ channels by chlorine, hypochlorous acid, and chloramines. J Biol Chem. 2010;285:9716–9728. doi: 10.1074/jbc.M109.073981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Honavar J, Samal AA, Bradley KM, Brandon A, Balanay J, Squadrito GL, MohanKumar K, Maheshwari A, Postlethwait EM, Matalon S, et al. Chlorine gas exposure causes systemic endothelial dysfunction by inhibiting endothelial nitric oxide synthase-dependent signaling. Am J Respir Cell Mol Biol. 2011;45:419–425. doi: 10.1165/rcmb.2010-0151OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.McGovern T, Day BJ, White CW, Powell WS, Martin JG. AEOL10150: a novel therapeutic for rescue treatment after toxic gas lung injury. Free Radic Biol Med. 2011;50:602–608. doi: 10.1016/j.freeradbiomed.2010.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Chang W, Chen J, Schlueter CF, Rando RJ, Pathak YV, Hoyle GW. Inhibition of chlorine-induced lung injury by the type 4 phosphodiesterase inhibitor rolipram. Toxicol Appl Pharmacol. 2012;263:251–258. doi: 10.1016/j.taap.2012.06.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hoyle GW, Hoyle CI, Chen J, Chang W, Williams RW, Rando RJ. Identification of triptolide, a natural diterpenoid compound, as an inhibitor of lung inflammation. Am J Physiol Lung Cell Mol Physiol. 2010;298:L830–L836. doi: 10.1152/ajplung.00014.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Pi J, Zhang Q, Woods CG, Wong V, Collins S, Andersen ME. Activation of Nrf2-mediated oxidative stress response in macrophages by hypochlorous acid. Toxicol Appl Pharmacol. 2008;226:236–243. doi: 10.1016/j.taap.2007.09.016. [DOI] [PubMed] [Google Scholar]
- 19.Woods CG, Fu J, Xue P, Hou Y, Pluta LJ, Yang L, Zhang Q, Thomas RS, Andersen ME, Pi J. Dose-dependent transitions in Nrf2-mediated adaptive response and related stress responses to hypochlorous acid in mouse macrophages. Toxicol Appl Pharmacol. 2009;238:27–36. doi: 10.1016/j.taap.2009.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem. 2005;74:739–789. doi: 10.1146/annurev.biochem.73.011303.074134. [DOI] [PubMed] [Google Scholar]
- 21.Zhang K, Shen X, Wu J, Sakaki K, Saunders T, Rutkowski DT, Back SH, Kaufman RJ. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell. 2006;124:587–599. doi: 10.1016/j.cell.2005.11.040. [DOI] [PubMed] [Google Scholar]
- 22.Li J, Ni M, Lee B, Barron E, Hinton DR, Lee AS. The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells. Cell Death Differ. 2008;15:1460–1471. doi: 10.1038/cdd.2008.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Winter J, Ilbert M, Graf PC, Ozcelik D, Jakob U. Bleach activates a redox-regulated chaperone by oxidative protein unfolding. Cell. 2008;135:691–701. doi: 10.1016/j.cell.2008.09.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Athar M, Khan WA, Mukhtar H. Effect of dietary tannic acid on epidermal, lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Sencar mice. Cancer Res. 1989;49:5784–5788. [PubMed] [Google Scholar]
- 25.Li C, Xu J, Li F, Chaudhary SC, Weng Z, Wen J, Elmets CA, Ahsan H, Athar M. Unfolded protein response signaling and MAP kinase pathways underlie pathogenesis of arsenic-induced cutaneous inflammation. Cancer Prev Res (Phila) 2011;4:2101–2109. doi: 10.1158/1940-6207.CAPR-11-0343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Song B, Scheuner D, Ron D, Pennathur S, Kaufman RJ. Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J Clin Invest. 2008;118:3378–3389. doi: 10.1172/JCI34587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Yadav AK, Doran SF, Samal AA, Sharma R, Vedagiri K, Postlethwait EM, Squadrito GL, Fanucchi MV, Roberts LJ, Patel RP, et al. Mitigation of chlorine gas lung injury in rats by postexposure administration of sodium nitrite. Am J Physiol Lung Cell Mol Physiol. 2011;300:L362–L369. doi: 10.1152/ajplung.00278.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Martin JG, Campbell HR, Iijima H, Gautrin D, Malo JL, Eidelman DH, Hamid Q, Maghni K. Chlorine-induced injury to the airways in mice. Am J Respir Crit Care Med. 2003;168:568–574. doi: 10.1164/rccm.200201-021OC. [DOI] [PubMed] [Google Scholar]
- 29.Vecchi C, Montosi G, Zhang K, Lamberti I, Duncan SA, Kaufman RJ, Pietrangelo A. ER stress controls iron metabolism through induction of hepcidin. Science. 2009;325:877–880. doi: 10.1126/science.1176639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.De Domenico I, Nemeth E, Nelson JM, Phillips JD, Ajioka RS, Kay MS, Kushner JP, Ganz T, Ward DM, Kaplan J. The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab. 2008;8:146–156. doi: 10.1016/j.cmet.2008.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 31.Xue X, Piao JH, Nakajima A, Sakon-Komazawa S, Kojima Y, Mori K, Yagita H, Okumura K, Harding H, Nakano H. Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha. J Biol Chem. 2005;280:33917–33925. doi: 10.1074/jbc.M505818200. [DOI] [PubMed] [Google Scholar]
- 32.Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science. 2012;338:768–772. doi: 10.1126/science.1224577. [DOI] [PubMed] [Google Scholar]
- 33.Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012;1823:1434–1443. doi: 10.1016/j.bbamcr.2012.01.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA. 2005;102:1906–1910. doi: 10.1073/pnas.0409808102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093. doi: 10.1126/science.1104742. [DOI] [PubMed] [Google Scholar]
- 36.Bosworth CA, Toledo JC, Jr, Zmijewski JW, Li Q, Lancaster JR., Jr Dinitrosyliron complexes and the mechanism(s) of cellular protein nitrosothiol formation from nitric oxide. Proc Natl Acad Sci USA. 2009;106:4671–4676. doi: 10.1073/pnas.0710416106. [DOI] [PMC free article] [PubMed] [Google Scholar]




